FLUZONE TRIVALENT NORTHERN HEMISPHERE (INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INAC) by Bamboo US BidCo LLC: new vaccine listing

FLUZONE TRIVALENT NORTHERN HEMISPHERE: new vaccine listing. Dated 126 days ago, it serves as a historical benchmark. Score 80/100. As of 2026-11-03, from U.S. FDA National Drug Code (NDC) Directory via openFDA.

Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA

Free preview: all 12 published fields of this record are shown below. Locked: 17 related FdaNdcDirectoryPulse records and the 5-column CSV export.

FieldValue
ProductFLUZONE TRIVALENT NORTHERN HEMISPHERE
Generic nameINFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
NDC83703-087
LabelerBamboo US BidCo LLC
Product typeVACCINE
Approval pathwayBLA
Application numberBLA103914
Dosage formINJECTION, SUSPENSION
RouteINTRAMUSCULAR
Active ingredientsINFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL; INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL
Marketing start2026-07-01
Package configurations1
Peer records CSV (18 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch FLUZONE TRIVALENT NORTHERN HEMISPHERE

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock FLUZONE TRIVALENT NORTHERN HEMISPHERE + all 18 records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL

  • Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
  • Record date: 2026-07-01
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all records free →

Top FdaNdcDirectoryPulse records (VACCINE first): Ensitrelvir Fumaric Acid (Ensitrelvir Fumaric Acid) by Shion · Norepinephrine Bitartrate by Northstar Rx LLC · Magnesium Sulfate (Magnesium Sulfate Heptahydrate) by SQUARE · Lutetium (Lu 177) chloride (Lutetium (Lu 177) chloride) by C · alirocumab (alirocumab) by SAMSUNG BIOLOGICS Co., Ltd. · Browse all by state and category →

LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Tue, 03 Nov 2026 18:09:00 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: FLUZONE TRIVALENT NORTHERN HEMISPHERE and 18 VACCINE peers

  • VACCINE FdaNdcDirectoryPulse records like this one: 18
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every VACCINE peer: $3,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more FdaNdcDirectoryPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

80 / 100 Launch Signal Score

  • Prescription or biologic product.
  • Brand or biologic launch.
  • Injectable: hospital and 503B relevance.

What is the FdaNdcDirectoryPulse record for FLUZONE TRIVALENT NORTHERN HEMISPHERE?

FLUZONE TRIVALENT NORTHERN HEMISPHERE by Bamboo US BidCo LLC: new vaccine listing (BLA) starting 2026-07-01.

How does FLUZONE TRIVALENT NORTHERN HEMISPHERE compare to other FdaNdcDirectoryPulse records?

It is 126 days old; check the official source for later updates before acting. Its Launch Signal Score of 80/100 puts it among the stronger signals in this feed.

FLUZONE TRIVALENT NORTHERN HEMISPHERE vs. top 3 peers

OrganizationLocationRecord date
FLUZONE TRIVALENT NORTHERN HEMISPHEREVACCINE2026-07-01
ComirnatyVACCINE2026-08-27
NUVAXOVID 2026-27VACCINE2026-08-27
ComirnatyVACCINE2026-08-27

Related records

FdaNdcDirectoryPulse: Vaccine FdaNdcDirectoryPulse: Biologic (BLA)

How to monitor FLUZONE TRIVALENT NORTHERN HEMISPHERE and peer biologic (bla) records

Get new FdaNdcDirectoryPulse records like FLUZONE TRIVALENT NORTHERN HEMISPHERE by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new listings in your categories

FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.

Often used together